APA (7th ed.) Citation

H, L., S, C., L, S., T, H., J, C., S, Z., . . . S, W. (2022). Integrated Analysis of the Cecal Microbiome and Plasma Metabolomics to Explore NaoMaiTong and Its Potential Role in Changing the Intestinal Flora and Their Metabolites in Ischemic Stroke. Frontiers in pharmacology, 12, 773722. https://doi.org/10.3389/fphar.2021.773722

Chicago Style (17th ed.) Citation

H, Lin, et al. "Integrated Analysis of the Cecal Microbiome and Plasma Metabolomics to Explore NaoMaiTong and Its Potential Role in Changing the Intestinal Flora and Their Metabolites in Ischemic Stroke." Frontiers in Pharmacology 12 (2022): 773722. https://doi.org/10.3389/fphar.2021.773722.

MLA (9th ed.) Citation

H, Lin, et al. "Integrated Analysis of the Cecal Microbiome and Plasma Metabolomics to Explore NaoMaiTong and Its Potential Role in Changing the Intestinal Flora and Their Metabolites in Ischemic Stroke." Frontiers in Pharmacology, vol. 12, 2022, p. 773722, https://doi.org/10.3389/fphar.2021.773722.